Exagen
Exagen Posts 43 Percent Increase in Q2 Revenues
The firm saw record revenues, order rates, and retention rates for its flagship Avise CTD test in the quarter.
Exagen Q1 Revenues Grow 10 Percent
Revenues from testing were $10.3 million, up from $9.6 million on increased testing volume.
Exagen, Allegheny Health Network Research and Autoimmunity Institutes Partner on Autoimmune Tests
Exagen will get a worldwide exclusive license to four families of inventions and the Autoimmunity Institute's clinical biobank.
Exagen, Emory University to Study of Long-Term Effects of COVID-19 on Autoimmune Disease
The study will evaluate the emergence of biomarkers that are indicators for autoimmune diseases and assess these biomarkers in mild and moderate COVID-19 patients.
In Brief This Week: Roche, GenMark, Ortho Clinical Diagnostics, Thermo Fisher Scientific, and More
News items for the in vitro diagnostics industry for the week of March 22, 2021.
Mar 23, 2021
Exagen Prices $60.1M Public Offering of Stock
May 11, 2020
Exagen Q1 Revenues Grow 3 Percent
Nov 25, 2019
Nov 12, 2019
Exagen Q3 Revenues Rise 27 Percent
Oct 14, 2019
William Blair, Cowen Initiate Coverage of Exagen
Sep 25, 2019
Sep 19, 2019
Exagen Goes Public at $14 per Share
Aug 20, 2018
CareFirst BCBS, Exagen Partner to Evaluate Lupus Dx
Sep 11, 2017